{"name":"Adverum Biotechnologies","slug":"adverum","ticker":"ADVM","exchange":"NASDAQ","domain":"adverum.com","description":"Adverum Biotechnologies, Inc. is a publicly traded clinical stage gene therapy company located in Redwood City, California. It is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration.","hq":"Redwood City, CA","founded":0,"employees":"","ceo":"Laurent Fischer","sector":"Gene Therapy / Ophthalmology","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$1.2B","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2034-06-01","label":"ADVM-053 patent cliff ($0.0B at risk)","drug":"ADVM-053","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ADVM-022","genericName":"ADVM-022","slug":"advm-022","indication":"Wet age-related macular degeneration","status":"phase_2"}]}],"pipeline":[{"name":"ADVM-022","genericName":"ADVM-022","slug":"advm-022","phase":"phase_2","mechanism":"ADVM-022 is an adeno-associated virus (AAV) vector-based gene therapy that targets the vascular endothelial growth factor A (VEGF-A) gene.","indications":["Wet age-related macular degeneration"],"catalyst":""}],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Adverum reported a net loss of $34.5 million for the fourth quarter and $141.4 million for the full year 2023.","drugName":"","sentiment":"neutral"},{"date":"2023-11-16","type":"deal","headline":"Adverum Biotechnologies Announces Collaboration with the University of California, San Francisco (UCSF)","summary":"Adverum partnered with UCSF to develop a gene therapy for inherited retinal diseases.","drugName":"","sentiment":"positive"},{"date":"2023-08-04","type":"trial","headline":"Adverum Biotechnologies Announces Positive Interim Results from Phase 1/2 Clinical Trial of ADVM-053","summary":"Adverum reported positive interim results from its Phase 1/2 clinical trial of ADVM-053.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5EQzllTTFiRVQyNklfcVVpLUlMVWtmODNidFZxRTJFMjh1am9jRU9Yb09SWWVPVTFHN3VoZ0JnY1llQkR0U25nbU1uMXpvWE5FZzY1Vk9tVVB5b0c0dEsw?oc=5","date":"2025-12-08","type":"pipeline","source":"ChartMill","summary":"ADVM Stock Price, Quote & Chart | ADVERUM BIOTECHNOLOGIES INC (NASDAQ:ADVM) - ChartMill","headline":"ADVM Stock Price, Quote & Chart | ADVERUM BIOTECHNOLOGIES INC (NASDAQ:ADVM)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPSlZNRVFIbzB1dnRyN0RDUkxRcFg4UnJBOXcwS0UwNTRqcFlSOE84b0tYbTUtZzdYQ3lZNHYzTnYtOUhra2VCSEQ4Z2k4aVFiS2RkUnpCU1k1a1NtWFkzMldKb2NJcWs4TnBWV1FwX0lPb1dxNXIxcEotZXRHMXAyTmxPX21tZ245eExzU20yU2R3NzhGXzhBenpZclp3bFp0N3c?oc=5","date":"2025-10-27","type":"deal","source":"The Business Journals","summary":"Pharma giant buys firm that once had big plans for Research Triangle Park - The Business Journals","headline":"Pharma giant buys firm that once had big plans for Research Triangle Park","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNN1dHQWV3NnZNT013d2g2SUxFZVNlTm1sVy1NYURRWjVyR0lQZEZjYy0ycnMwUlhYSk5BWnUtMWJVd29FVmtUMU1mS1RfVi1NNV83ZlYzekRVT2x5bzFJVklRbzNuaHN3YTFUalVPU1AzMTFLOVVjU1lyUGtKY3hkeGJINi13VGRqcU5QRGFxTmw5ZXUxbWNQOURRMFU?oc=5","date":"2025-10-24","type":"deal","source":"PR Newswire","summary":"Lilly to Acquire Adverum Biotechnologies - PR Newswire","headline":"Lilly to Acquire Adverum Biotechnologies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFA3akVMUTdRY0ZlVmF0ZkJHd041OGlERHo5bEowYnVZVHJRM05reVQtS0xOR1VCbzduLXY5djJyOUxMTm1hZmstZk0xRDZCaUowYlNJ?oc=5","date":"2025-10-24","type":"deal","source":"firstwordpharma.com","summary":"Lilly agrees to buy Adverum to expand into eye gene therapies - firstwordpharma.com","headline":"Lilly agrees to buy Adverum to expand into eye gene therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPcTBSYXhSYjBFcGNWNmNBUjNtM0cwRXVPeEg2R1BEWGZ5clRBWEE3UkpsTnFFdWNfcWJvWWVxb1VlLWtVZVgyZjNSQXBqUEhRY2s3VnBIZWRaTDVjcjRBWklOU0ZyUkZZZ2YwanRRbFF6Qmo5SGdLeC1BMVdJOXFlczJqTzNQckJBT2pTaHpWbDBTbUdmV293UlhHQkZUTzhNandNa0tOekQ0OThUeTNGY3d6Z0RpaU1YbkpuMQ?oc=5","date":"2025-10-24","type":"deal","source":"Investing.com","summary":"Adverum stock soars after Lilly announces acquisition deal - Investing.com","headline":"Adverum stock soars after Lilly announces acquisition deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNaFhGRHZkUGJFVmpYbWNneFJIRjBOZDgxMGQycU01SlUxeV94REt2WVdlVGFGa3RoOWpCV0hNb01FamNlSEdaZ3NhREpXeVl3eVBkZGdqLXhOT2ZjVUhpejE0TXl1V0dESjB6MjczWXNMNld6SF85Ti1rSEdENWpSMHRB?oc=5","date":"2025-10-24","type":"deal","source":"Yahoo Finance","summary":"Eli Lilly to buy Adverum, General Dynamics stock hits new record - Yahoo Finance","headline":"Eli Lilly to buy Adverum, General Dynamics stock hits new record","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-03","type":"pipeline","source":"simplywall.st","summary":"After losing 28% in the past year, Adverum Biotechnologies, Inc. (NASDAQ:ADVM) institutional owners must be relieved by the recent gain - simplywall.st","headline":"After losing 28% in the past year, Adverum Biotechnologies, Inc. (NASDAQ:ADVM) institutional owners must be relieved by ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPdjNTS2p1ZnRERmpxcENRS0U4RXp6dDNVMkRuajkxcmJsMVRnamkxanpVeENPcHB2MUxYckM3UHRmWFdjelZyUkgwX1BaZGlaeXBwMlpQcDNSTnZFYk10R1NFcUhIbmpMcWNPWFRNVUppZkFRdlMxcVBENDM3a3pCYnMzemR3VHVRWUsxclRzaVBRZ25yX0JiSzBHNU9hQlRzQzhvRzNn?oc=5","date":"2025-09-30","type":"pipeline","source":"Barchart","summary":"2 Penny Stocks That Wall Street Believes Can Soar Over 200% - Barchart","headline":"2 Penny Stocks That Wall Street Believes Can Soar Over 200%","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-15","type":"pipeline","source":"simplywall.st","summary":"Adverum Biotechnologies Up 22%, Insiders Still Down After US$526.8k Purchase - simplywall.st","headline":"Adverum Biotechnologies Up 22%, Insiders Still Down After US$526.8k Purchase","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1vOWQ1MXBCUUd2YXFpQnRBVF9Dakwzb2VFb0pEbm9kcnI0anhfM3MzakFJRVFkVmxvc1RhOEVHY09STkVicHkyZ0l3ajFPWjRMWlRz?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"ADVM Stock Price, News & Analysis - Stock Titan","headline":"ADVM Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNRXlZM1dSbVpqSWpOdkwtNFJ6WEhnQTNFRmdkeG01ejR4X0ZHckgyZ0dOYURYdVN4U0hDN2EySVQ1Q1dnMTRoNk5BNGt4VEJkSVh2NXVxVDlZMnZEY29vVFRfUnlrY3hwNE1ZQ0FHelVPckg0bjViMlkzTVJBeHFuTGNnVDBJZDNHVkxYOGJwQVJhSmRJXzJBS3dwbW1ZeWM?oc=5","date":"2024-02-06","type":"pipeline","source":"The Pharma Letter","summary":"Well-funded advanced therapy firm takes aim at wet AMD - The Pharma Letter","headline":"Well-funded advanced therapy firm takes aim at wet AMD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxObDh4em1kZWtkTGhGb1R3a3d0N21uQThYcjJJamJNU2FuT3NieTVjeTFpNVRwSlBsYVhRUDdvZUVVcWxmS0didnJ4LTlsek1xYktsYWZsTjhlVFdWTG9ZSVk5eHhjc2F2Y3FsSmhwdGE2OEtKN2hJMThveTg4bVNjZHhWSGFtalpBeHJoeG1tUXYwWWhkaVMxb1B2LUwtWUVqQ3pLT1BweF9aNVgxbEtMQUl0R3ZZVUkt?oc=5","date":"2022-07-07","type":"pipeline","source":"Fierce Biotech","summary":"Adverum lays off 78 employees, bets it all on embattled eye treatment - Fierce Biotech","headline":"Adverum lays off 78 employees, bets it all on embattled eye treatment","sentiment":"neutral"}],"patents":[{"drugName":"ADVM-053","drugSlug":"generic","patentNumber":"","type":"Patent Cliff","expiryDate":"2034-06-01","territory":"US","annualRevenue":0}],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Spark Therapeutics","Regeneron Pharmaceuticals","Biogen"],"therapeuticFocus":["Ophthalmology","Gene Therapy"],"financials":null,"yahoo":null}